Report Detail

Pharma & Healthcare Global Natural Killer (NK) Cell Therapeutics Market Professional Survey Report 2019

  • RnM3769125
  • |
  • 20 September, 2019
  • |
  • Global
  • |
  • 109 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Natural killer cells are a type of cytotoxic lymphocyte, which is a component of the innate immune system.

The global Natural Killer (NK) Cell Therapeutics market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Natural Killer (NK) Cell Therapeutics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Natural Killer (NK) Cell Therapeutics market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Natural Killer (NK) Cell Therapeutics in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Natural Killer (NK) Cell Therapeutics manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Chipscreen Biosciences (China)
Affimed NV (Netherlands)
Altor BioScience Corporation (USA)
Innate Pharma SA (France)
Takeda Pharmaceutical (Japan)
Sorrento Therapeutics Inc. (USA)
NantKwest Inc. (USA)
Bristol-Myers Squibb (USA)
NKT Therapeutics (USA)

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Mogamulizumab
Lorvotuzumab Mertansine
Others

Segment by Application
Cancer
Cardiovascular Diseases
Others


Table of Contents

    Executive Summary

      1 Industry Overview of Natural Killer (NK) Cell Therapeutics

      • 1.1 Definition of Natural Killer (NK) Cell Therapeutics
      • 1.2 Natural Killer (NK) Cell Therapeutics Segment by Type
        • 1.2.1 Global Natural Killer (NK) Cell Therapeutics Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 Mogamulizumab
        • 1.2.3 Lorvotuzumab Mertansine
        • 1.2.4 Others
      • 1.3 Natural Killer (NK) Cell Therapeutics Segment by Applications
        • 1.3.1 Global Natural Killer (NK) Cell Therapeutics Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Cancer
        • 1.3.3 Cardiovascular Diseases
        • 1.3.4 Others
      • 1.4 Global Natural Killer (NK) Cell Therapeutics Overall Market
        • 1.4.1 Global Natural Killer (NK) Cell Therapeutics Revenue (2014-2025)
        • 1.4.2 Global Natural Killer (NK) Cell Therapeutics Production (2014-2025)
        • 1.4.3 North America Natural Killer (NK) Cell Therapeutics Status and Prospect (2014-2025)
        • 1.4.4 Europe Natural Killer (NK) Cell Therapeutics Status and Prospect (2014-2025)
        • 1.4.5 China Natural Killer (NK) Cell Therapeutics Status and Prospect (2014-2025)
        • 1.4.6 Japan Natural Killer (NK) Cell Therapeutics Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Natural Killer (NK) Cell Therapeutics Status and Prospect (2014-2025)
        • 1.4.8 India Natural Killer (NK) Cell Therapeutics Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Natural Killer (NK) Cell Therapeutics
      • 2.3 Manufacturing Process Analysis of Natural Killer (NK) Cell Therapeutics
      • 2.4 Industry Chain Structure of Natural Killer (NK) Cell Therapeutics

      3 Development and Manufacturing Plants Analysis of Natural Killer (NK) Cell Therapeutics

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Natural Killer (NK) Cell Therapeutics Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Natural Killer (NK) Cell Therapeutics
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Natural Killer (NK) Cell Therapeutics Production and Capacity Analysis
      • 4.2 Natural Killer (NK) Cell Therapeutics Revenue Analysis
      • 4.3 Natural Killer (NK) Cell Therapeutics Price Analysis
      • 4.4 Market Concentration Degree

      5 Natural Killer (NK) Cell Therapeutics Regional Market Analysis

      • 5.1 Natural Killer (NK) Cell Therapeutics Production by Regions
        • 5.1.1 Global Natural Killer (NK) Cell Therapeutics Production by Regions
        • 5.1.2 Global Natural Killer (NK) Cell Therapeutics Revenue by Regions
      • 5.2 Natural Killer (NK) Cell Therapeutics Consumption by Regions
      • 5.3 North America Natural Killer (NK) Cell Therapeutics Market Analysis
        • 5.3.1 North America Natural Killer (NK) Cell Therapeutics Production
        • 5.3.2 North America Natural Killer (NK) Cell Therapeutics Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Natural Killer (NK) Cell Therapeutics Import and Export
      • 5.4 Europe Natural Killer (NK) Cell Therapeutics Market Analysis
        • 5.4.1 Europe Natural Killer (NK) Cell Therapeutics Production
        • 5.4.2 Europe Natural Killer (NK) Cell Therapeutics Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Natural Killer (NK) Cell Therapeutics Import and Export
      • 5.5 China Natural Killer (NK) Cell Therapeutics Market Analysis
        • 5.5.1 China Natural Killer (NK) Cell Therapeutics Production
        • 5.5.2 China Natural Killer (NK) Cell Therapeutics Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Natural Killer (NK) Cell Therapeutics Import and Export
      • 5.6 Japan Natural Killer (NK) Cell Therapeutics Market Analysis
        • 5.6.1 Japan Natural Killer (NK) Cell Therapeutics Production
        • 5.6.2 Japan Natural Killer (NK) Cell Therapeutics Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Natural Killer (NK) Cell Therapeutics Import and Export
      • 5.7 Southeast Asia Natural Killer (NK) Cell Therapeutics Market Analysis
        • 5.7.1 Southeast Asia Natural Killer (NK) Cell Therapeutics Production
        • 5.7.2 Southeast Asia Natural Killer (NK) Cell Therapeutics Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Natural Killer (NK) Cell Therapeutics Import and Export
      • 5.8 India Natural Killer (NK) Cell Therapeutics Market Analysis
        • 5.8.1 India Natural Killer (NK) Cell Therapeutics Production
        • 5.8.2 India Natural Killer (NK) Cell Therapeutics Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Natural Killer (NK) Cell Therapeutics Import and Export

      6 Natural Killer (NK) Cell Therapeutics Segment Market Analysis (by Type)

      • 6.1 Global Natural Killer (NK) Cell Therapeutics Production by Type
      • 6.2 Global Natural Killer (NK) Cell Therapeutics Revenue by Type
      • 6.3 Natural Killer (NK) Cell Therapeutics Price by Type

      7 Natural Killer (NK) Cell Therapeutics Segment Market Analysis (by Application)

      • 7.1 Global Natural Killer (NK) Cell Therapeutics Consumption by Application
      • 7.2 Global Natural Killer (NK) Cell Therapeutics Consumption Market Share by Application (2014-2019)

      8 Natural Killer (NK) Cell Therapeutics Major Manufacturers Analysis

      • 8.1 Chipscreen Biosciences (China)
        • 8.1.1 Chipscreen Biosciences (China) Natural Killer (NK) Cell Therapeutics Production Sites and Area Served
        • 8.1.2 Chipscreen Biosciences (China) Product Introduction, Application and Specification
        • 8.1.3 Chipscreen Biosciences (China) Natural Killer (NK) Cell Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 Affimed NV (Netherlands)
        • 8.2.1 Affimed NV (Netherlands) Natural Killer (NK) Cell Therapeutics Production Sites and Area Served
        • 8.2.2 Affimed NV (Netherlands) Product Introduction, Application and Specification
        • 8.2.3 Affimed NV (Netherlands) Natural Killer (NK) Cell Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 Altor BioScience Corporation (USA)
        • 8.3.1 Altor BioScience Corporation (USA) Natural Killer (NK) Cell Therapeutics Production Sites and Area Served
        • 8.3.2 Altor BioScience Corporation (USA) Product Introduction, Application and Specification
        • 8.3.3 Altor BioScience Corporation (USA) Natural Killer (NK) Cell Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 Innate Pharma SA (France)
        • 8.4.1 Innate Pharma SA (France) Natural Killer (NK) Cell Therapeutics Production Sites and Area Served
        • 8.4.2 Innate Pharma SA (France) Product Introduction, Application and Specification
        • 8.4.3 Innate Pharma SA (France) Natural Killer (NK) Cell Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 Takeda Pharmaceutical (Japan)
        • 8.5.1 Takeda Pharmaceutical (Japan) Natural Killer (NK) Cell Therapeutics Production Sites and Area Served
        • 8.5.2 Takeda Pharmaceutical (Japan) Product Introduction, Application and Specification
        • 8.5.3 Takeda Pharmaceutical (Japan) Natural Killer (NK) Cell Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 Sorrento Therapeutics Inc. (USA)
        • 8.6.1 Sorrento Therapeutics Inc. (USA) Natural Killer (NK) Cell Therapeutics Production Sites and Area Served
        • 8.6.2 Sorrento Therapeutics Inc. (USA) Product Introduction, Application and Specification
        • 8.6.3 Sorrento Therapeutics Inc. (USA) Natural Killer (NK) Cell Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 NantKwest Inc. (USA)
        • 8.7.1 NantKwest Inc. (USA) Natural Killer (NK) Cell Therapeutics Production Sites and Area Served
        • 8.7.2 NantKwest Inc. (USA) Product Introduction, Application and Specification
        • 8.7.3 NantKwest Inc. (USA) Natural Killer (NK) Cell Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served
      • 8.8 Bristol-Myers Squibb (USA)
        • 8.8.1 Bristol-Myers Squibb (USA) Natural Killer (NK) Cell Therapeutics Production Sites and Area Served
        • 8.8.2 Bristol-Myers Squibb (USA) Product Introduction, Application and Specification
        • 8.8.3 Bristol-Myers Squibb (USA) Natural Killer (NK) Cell Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.8.4 Main Business and Markets Served
      • 8.9 NKT Therapeutics (USA)
        • 8.9.1 NKT Therapeutics (USA) Natural Killer (NK) Cell Therapeutics Production Sites and Area Served
        • 8.9.2 NKT Therapeutics (USA) Product Introduction, Application and Specification
        • 8.9.3 NKT Therapeutics (USA) Natural Killer (NK) Cell Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.9.4 Main Business and Markets Served

      9 Development Trend of Analysis of Natural Killer (NK) Cell Therapeutics Market

      • 9.1 Global Natural Killer (NK) Cell Therapeutics Market Trend Analysis
        • 9.1.1 Global Natural Killer (NK) Cell Therapeutics Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Natural Killer (NK) Cell Therapeutics Regional Market Trend
        • 9.2.1 North America Natural Killer (NK) Cell Therapeutics Forecast 2019-2025
        • 9.2.2 Europe Natural Killer (NK) Cell Therapeutics Forecast 2019-2025
        • 9.2.3 China Natural Killer (NK) Cell Therapeutics Forecast 2019-2025
        • 9.2.4 Japan Natural Killer (NK) Cell Therapeutics Forecast 2019-2025
        • 9.2.5 Southeast Asia Natural Killer (NK) Cell Therapeutics Forecast 2019-2025
        • 9.2.6 India Natural Killer (NK) Cell Therapeutics Forecast 2019-2025
      • 9.3 Natural Killer (NK) Cell Therapeutics Market Trend (Product Type)
      • 9.4 Natural Killer (NK) Cell Therapeutics Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Natural Killer (NK) Cell Therapeutics Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Summary:
        Get latest Market Research Reports on Natural Killer (NK) Cell Therapeutics. Industry analysis & Market Report on Natural Killer (NK) Cell Therapeutics is a syndicated market report, published as Global Natural Killer (NK) Cell Therapeutics Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Natural Killer (NK) Cell Therapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

        Last updated on

        REPORT YOU MIGHT BE INTERESTED

        Purchase this Report

        $3,500.00
        $5,250.00
        $7,000.00
        2,751.00
        4,126.50
        5,502.00
        3,307.50
        4,961.25
        6,615.00
        543,200.00
        814,800.00
        1,086,400.00
        295,540.00
        443,310.00
        591,080.00
        Credit card Logo

        Related Reports


        Reason to Buy

        Request for Sample of this report